From August 28, 2023 to September 30, 2023, the company has repurchased 140,646 shares, representing 0.19% for $0.12 million. With this, the company has completed the repurchase of 140,646 shares, representing 0.19% for $0.12 million under the buyback announced on August 30, 2023.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.466 USD | -5.71% | -5.87% | -75.77% |
May. 14 | Transcript : The Oncology Institute, Inc., Q1 2024 Earnings Call, May 14, 2024 | |
May. 14 | The Oncology Institute, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-75.77% | 34.59M | |
+22.10% | 87.14B | |
-24.46% | 75.59B | |
+1.76% | 26.78B | |
+4.56% | 17.89B | |
-14.64% | 16.44B | |
+2.42% | 15.68B | |
+69.07% | 13.3B | |
+76.05% | 13.06B | |
+2.92% | 12.54B |
- Stock Market
- Equities
- TOI Stock
- News The Oncology Institute, Inc.
- Tranche Update on The Oncology Institute, Inc.'s Equity Buyback Plan announced on August 30, 2023.